Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PreFaiR: Mifepristone Pretreatment for Early Pregnancy Failure
NCT02012491Phase 3Completed
- Sponsor
- University of Pennsylvania
- Start
- Jan 2014
- Primary completion
- May 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of mifepristone in spontaneous abortion (2 arms), sponsored by University of Pennsylvania. Primary endpoints: Gestational Sac Expulsion With One Treatment Dose on Day 3, Gestational Sac Expulsion by the Second Follow-up Visit at Day 8 and 2 more. Started Jan 2014; status: completed.
02
Drugs
mifepristone
03
Conditions
spontaneous abortion
Beyond the preview
Go deeper on NCT02012491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02012491.